Erez Chimovits - Net Worth and Insider Trading
Erez Chimovits Net Worth
The estimated net worth of Erez Chimovits is at least $2 Million dollars as of 2024-05-10. Erez Chimovits is the Director, 10% Owner of BiomX Inc and owns about 2,313,489 shares of BiomX Inc (PHGE) stock worth over $844,423. Erez Chimovits is the Director, 10% Owner of LogicBio Therapeutics Inc and owns about 296,296 shares of LogicBio Therapeutics Inc (LOGC) stock worth over $613,333. Erez Chimovits is also the Director of Eledon Pharmaceuticals Inc and owns about 176,852 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $424,445. Besides these, Erez Chimovits also holds Logic Devices Inc (LOGC) . Details can be seen in Erez Chimovits's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Erez Chimovits has not made any transactions after 2020-10-01 and currently still holds the listed stock(s).
Transaction Summary of Erez Chimovits
Erez Chimovits Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Erez Chimovits owns 5 companies in total, including LogicBio Therapeutics Inc (LOGC) , BiomX Inc (PHGE.U) , and Eledon Pharmaceuticals Inc (ELDN) among others .
Click here to see the complete history of Erez Chimovits’s form 4 insider trades.
Insider Ownership Summary of Erez Chimovits
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LOGC | LogicBio Therapeutics Inc | 2020-10-01 | director |
| PHGE.U | BiomX Inc | 2020-03-25 | director & 10 percent owner |
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-02 | director |
 | | 2020-09-15 | director |
| | 2019-12-19 | director & 10 percent owner |
Erez Chimovits Latest Holdings Summary
Erez Chimovits currently owns a total of 4 stocks. Among these stocks, Erez Chimovits owns 2,313,489 shares of BiomX Inc (PHGE) as of December 19, 2019, with a value of $844,423 and a weighting of 44.86%. Erez Chimovits owns 296,296 shares of LogicBio Therapeutics Inc (LOGC) as of October 1, 2020, with a value of $613,333 and a weighting of 32.59%. Erez Chimovits also owns 176,852 shares of Eledon Pharmaceuticals Inc (ELDN) as of May 2, 2019, with a value of $424,445 and a weighting of 22.55%. The other 1 stocks Logic Devices Inc (LOGC) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Erez Chimovits
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PHGE | BiomX Inc | 2019-12-19 | 2,313,489 | 0.37 | 844,423 |
| LOGC | LogicBio Therapeutics Inc | 2020-10-01 | 296,296 | 2.07 | 613,333 |
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-02 | 176,852 | 2.40 | 424,445 |
| LOGC | Logic Devices Inc | 2018-10-23 | 3,487,760 | 0.00 | 0 |
Holding Weightings of Erez Chimovits
Erez Chimovits Form 4 Trading Tracker
According to the SEC Form 4 filings, Erez Chimovits has made a total of 3 transactions in BiomX Inc (PHGE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in BiomX Inc is the acquisition of 4,000 shares on December 19, 2019, which cost Erez Chimovits around $35,600.
According to the SEC Form 4 filings, Erez Chimovits has made a total of 1 transactions in LogicBio Therapeutics Inc (LOGC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in LogicBio Therapeutics Inc is the acquisition of 1,481,482 shares on October 1, 2020, which cost Erez Chimovits around $9 Million.
According to the SEC Form 4 filings, Erez Chimovits has made a total of 0 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 35,901 shares on May 2, 2019, which cost Erez Chimovits around $2 Million.
More details on Erez Chimovits's insider transactions can be found in the Insider Trading History of Erez Chimovits table.Insider Trading History of Erez Chimovits
- 1
Erez Chimovits Trading Performance
GuruFocus tracks the stock performance after each of Erez Chimovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erez Chimovits is -11.5%. GuruFocus also compares Erez Chimovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erez Chimovits within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Erez Chimovits's insider trading performs compared to the benchmark.
Performance of Erez Chimovits
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.82 | | | | | |
| Relative Return to S&P 500(%) | -10.48 | | | | | |
Erez Chimovits Ownership Network
Erez Chimovits Owned Company Details
What does LogicBio Therapeutics Inc do?
Who are the key executives at LogicBio Therapeutics Inc?
Erez Chimovits is the director of LogicBio Therapeutics Inc. Other key executives at LogicBio Therapeutics Inc include Chief Scientific Officer Mariana Nacht , Chief Medical Officer Daniel Gruskin , and Interim CFO Joshua Blacher .
LogicBio Therapeutics Inc (LOGC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of LogicBio Therapeutics Inc (LOGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LogicBio Therapeutics Inc (LOGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
LogicBio Therapeutics Inc (LOGC)'s detailed insider trading history can be found in Insider Trading Tracker table.
LogicBio Therapeutics Inc Insider Transactions
Erez Chimovits Mailing Address
Above is the net worth, insider trading, and ownership report for Erez Chimovits. You might contact Erez Chimovits via mailing address: P.o. Box 4023, Herzliya Pituach L3 4614001.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
